KR20120083648A - Composition of antismoking aid containing damascone - Google Patents

Abstract

PURPOSE: A smoking cessation aid composition containing damascone is provided to ensure similar taste and flavor with tobacco and to help smoking cessation. CONSTITUTION: A smoking cessation aid composition contains 0.001-10 wt% of damascone and 90.99.999 wt% of propylene glycol. A smoking cessation aid contains 0.001-10 wt% of damascene, 30-90 wt% of propylene glycol, and 5-60 wt% of glycerin. The damascone includes alpha-damascone, beta-damascone, or delta-damascone. The composition additionally contains 0.001-10 weight parts of vitamins or amino acids, aroma or fruit perfume. contains the flavor of strawberry, melon, peach, blueberry, banana, lemon, mango, apple, orange, kiwi, pineapple, or grape.

Description

Composition of antismoking aid containing damascone

The present invention relates to a smoking cessation adjuvant composition, more specifically the same as when smoking, including damascon (alpha-damascone, beta-damascone and delta-damascone) and propylene glycol or damascone, propylene glycol and glycerin The smoke is generated, and the taste and smell of tobacco, so it has a tobacco substitute or smoking desire inhibiting ability to the smoking relieving effect relates to a Damascon-containing anti-smoking supplement composition.

Smoking is the act of burning cigarettes and inhaling the smoke, which is estimated to contain as many as 4000 kinds of toxic chemicals. When cigarettes are burned, their central temperature reaches 900 degrees Celsius. At this high temperature, organic substances undergo various processes such as pyrolysis, thermal synthesis, distillation, sublimation, hydrogenation, oxidation, and dehydration. Carbon monoxide, nicotine and tar are among the ingredients known to be the most harmful to health.

Carbon monoxide is a colorless, odorless gas that results from incomplete combustion when the fuel burns with a lack of oxygen. There are red blood cells in the blood of our body, and there is a protein called hemoglobin inside the red blood cells. Hemoglobin is iron-bonded in the center, and oxygen binds to hemoglobin, which can carry oxygen to every corner of our body. However, the binding force for binding carbon monoxide to iron of hemoglobin is about 400 times greater than that of oxygen. Therefore, when carbon monoxide accumulates in the air, when carbon monoxide enters our lungs, carbon monoxide will preferentially adhere to hemoglobin, resulting in the inability to transport oxygen. Usually, the oxygen utilization rate of smokers is 20 to 30 times lower than that of non-smokers, resulting in a decrease in the partial pressure of oxygen in the blood and a lack of circulation of blood. When the concentration of carbon monoxide in the blood reaches 2%, the central nervous system can slow down and memory can decline.

Nicotine is a type of alkaloid, the secondary metabolite of plants, which is mainly present in the leaves of tobacco plants such as tobacco and is a basic organic compound. Nicotine, although weaker than caffeine, has unique pharmacological properties that act as a stimulant or stabilize the nerves. Absorption of much larger amounts of nicotine than the amount of nicotine in cigarette smoke is toxic, and many public health authorities see nicotine as the cause of tobacco poisoning. If nicotine is deficient in part, smoking desire is caused by deficiency. If nicotine is not continuously administered, withdrawal phenomenon occurs. This phenomenon is called nicotine poisoning. Nicotine affects nerves, so lacking a certain amount causes smoking cravings due to deficiency. Nicotine acts as a pleasure and sedative because it affects metabolism, hormones, blood vessels, and the brain in a variety of ways, but it acts as an anesthetic to prevent consciousness, not as a direct therapeutic.

Tar is a substance in which the fine particles produced when the cigarette smoke is put into the mouth and exhaled are concentrated. It is dark brown and becomes a liquid when cooled and is known as a carcinogen. Tar is a poisonous substance, commonly called tobacco, produced by the burning of any plant and contains thousands of toxic chemicals in it. Most of the detoxification of tobacco to our health is caused by various toxic and carcinogens contained in this tar, and contains about 20 kinds of A-class carcinogens. Tar itself is highly toxic and can kill small animals and insects in small amounts, so it was previously used to collect cigarette butts to prevent the worms from sinking in the toilet and to combat snakes in the mountains. The unique taste of tobacco comes from this tar, and the tar enters the lungs through tobacco smoke, penetrates into the blood, damaging all the cells of our body and all organs, and acts directly on the gums and bronchus to cut epidermal cells. It can destroy or cause chronic inflammation. The amount of tar that is inhaled when you smoke a cigarette is usually less than 10 mg. The amount of tar that a person gathers a pack of cigarettes a day is enough to fill a glass.

Many smokers are said to be dependent on tobacco because they know that they are smoking and know that it is difficult to quit, even though they know the actual risks of disease-induced illness. Nevertheless, millions of smokers have quit smoking without medical assistance, and millions have changed the frequency, location and time of smoking as social behavior changes. Indeed, in the United Kingdom and several other countries, the number of people who quit smoking is similar to the number of smokers. Although smoking is addictive overnight, it is important to recognize that smoking is possible if you are motivated and willing.

Therefore, nicotine patches coated with nicotine processed in a gel type on the surface in contact with the skin in the form of a paste attached when there is muscle pain, without containing harmful ingredients of tobacco as described above, Nicotine gum, candy-type sweetness, nicotine candy that suppresses the desire to eat after quitting smoking and reduces the concern about weight gain, and non-smoking needles and antidepressants as other supplements. Korean Patent Publication No. 2004-89175 discloses chlorella, A smoking cessation aid mainly composed of green tea and lactoone, etc., Korean Patent No. 658604, a non-smoking supplement composition comprising a mixture of Angelica, breeding, and sweet ginseng, and Korean Patent No. 370340 include a tobacco substitute composition consisting of worms, licorice and teas. , Korean Patent Publication No. 2003-93416 discloses a smoking cessation aid consisting of potassium aluminum sulfate, roots, cinnamon and mint, , Honeysuckle and aeyeop Oriental tobacco substitutes herbal composition, and Korea Patent Publication No. 2004-48322 comprises a call has for Oriental tobacco herbal composition is disclosed comprising a honeysuckle, and gwakhyang bakhayeop.

On the other hand, damascon is a natural damascon beta-damascone (β-damascone, Chemical Formula 1), synthetic damascones alpha-damascone (α-damascone, Chemical Formula 2) and delta-damascone (δ-damascone, Chemical Formula) 3) are all flavored tobacco ingredients and flavors.

Therefore, a composition containing damascone is disclosed as described above, and Korean Patent Laid-Open Publication No. 2010-28182 discloses an aqueous nicotine solution for electronic cigarettes containing damascon as a flavor enhancer, and Korean Patent No. 844445 as a flavor enhancer. Electric heating cigarettes including cones and Korean Patent Publication No. 34029 discloses an inhalable composition comprising nicotine including beta-damascone as a flavor component.

However, tobacco-related compositions including damascone and beta-damascone have been disclosed as described above, but non-smoking aid compositions including alpha-damascone, beta-damascone and delta-damascone are not disclosed.

Therefore, the present inventors did not contain carbon monoxide, tar and nicotine, etc., which are harmful components of tobacco, and as a result of research on a smoking cessation aid composition which can give a feeling similar to smoking, alpha-damascone, beta-damascone and The composition containing delta-damascone and propylene glycol as an essential component generates smoke similar to smoking and has a similar taste and aroma as smoking, thus confirming that it can help to quit smoking due to smoking suppression effect and completed the present invention. .

Accordingly, the problem to be solved by the present invention is the same tobacco taste and aroma as when smoking with damascon (alpha-damascone, beta-damascone and delta-damascone), propylene glycol or damascone, propylene glycol and glycerin and smoking To suppress the desire to provide an excellent anti-smoking effect Damascon containing anti-smoking aid composition.

Anti-smoking aid composition for solving the above problems 100% by weight,

(1) 0.001-10% by weight of damascon; And

    Propylene glycol 90-99.999% by weight; or

(2) 0.001-10 wt% of damascon;

    Propylene glycol 30-90 wt%; And

    5 to 60% by weight glycerin;

To include the same tobacco flavor and aroma as when smoking and smoking cessation aid composition, characterized in that it has a smoking desire suppression effect.

The anti-smoking adjuvant composition of the above (1) or (2) may be used by filling into a conventional electronic cigarette cartridge.

Damascon of (1) or (2) may be at least one selected from the group consisting of alpha-damascone, beta-damascone and delta-damascone.

Since the addition of damascone in the preparation of the anti-smoking adjuvant composition of the above (1) or (2) according to the present invention, the tobacco taste and aroma or palatability similar to smoking are excellent without adding nicotine.

If the Damascon content is less than 0.001% by weight in the smoking cessation aid composition (1) or (2), the taste and taste may not be low because the tobacco taste and aroma may be lowered. . The damascon content of the smoking cessation aid composition (1) or (2) is preferably 0.01 to 5% by weight.

If the propylene glycol content of the non-smoking adjuvant composition (2) is less than 30% by weight, there is a problem that each composition is not uniformly mixed. Propylene glycol content of the smoking cessation aid composition (2) is preferably 50 to 70% by weight.

Propylene glycol of the non-smoking adjuvant composition (1) or (2) has the effect of generating smoke as a solvent, but not very similar to smoking, but when glycerin is used together with propylene glycol as a non-smoking adjuvant composition (2) to glycerin As a result of the increase in the amount of smoke generated smoke very similar to the smoking can give a very similar feeling when smoking.

The glycerin content of the smoking cessation aid composition (2) is preferably 20 to 40% by weight.

To the non-smoking supplement composition (1) or (2) to 0.001 ~ 10 parts by weight of vitamins and amino acids as general nutrients, aroma and fruit flavor as a flavoring agent based on 100 parts by weight of the non-smoking supplement composition (1) or (2) Can be added.

The vitamin is one selected from the group consisting of vitamin A, retinol, beta carotene, thiamine, riboflavin, niacin, vitamin C, vitamin B6, pantothenic acid, vitamin B12, folic acid, vitamin D, vitamin E, vitamin K, vitamins and thiamine It may be abnormal.

The amino acid may be at least one selected from the group consisting of isoleucine, leucine, lysine, methionine, cysteine, phenylalanine, tyrosine, threonine, tryptophan, valine, histidine, arginine, aspartic acid, glutamic acid, glycine, proline and serine.

The aroma is menthol, vanillin, chocolate, coffee, xylitol, phytoncide, peppermint, spearmint, chamomile, eucalyptus, thyme, geranium, jasmine, rosemary, lavender, lemongrass, pine needles, clobo, sage, bergamot, basil, bal It may be one or more selected from the group consisting of Lillian, Hishop, Tea Tree, Mir and Juniper.

The fruit flavor is a group consisting of strawberry flavor, melon flavor, peach flavor, blueberry flavor, banana flavor, lemon flavor, mango flavor, apple flavor, orange flavor, grapefruit flavor, plum flavor, kiwi flavor, flavor, pineapple flavor and grape flavor It may be at least one selected from.

In addition to the nutrients and flavoring agents, benzyl alcohol, benzyl alcohol, phenylethyl alcohol, isophorone, anisaldehyde, benzaldehyde, solanone, etc. , Damascenone, methylpyrazine, 2,6-dimethylpyrazine, ethylpyrazine, 2,5-dimethylpyrazine or 2-ethyl-6-vinylpyrazine may be further added.

Since the anti-smoking supplement composition according to the present invention was prepared by adding Damascon, it has the same tobacco taste and aroma as smoking, and does not contain harmful ingredients such as tar, carbon monoxide, and nicotine generated during smoking, thus harming the health of smokers. It does not have an effect, and smokers have a cigarette substitute or smoking desire suppression effect is helpful to quit smoking.

Hereinafter, preferred embodiments of the present invention will be described. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms.

<Example 1> Damascone and propylene glycol-containing non-smoking adjuvant composition

0.001 g of beta-damascone and 99.999 g of propylene glycol were mixed to prepare a non-smoking adjuvant composition containing damascon and propylene glycol.

<Examples 2-11> Damascone and propylene glycol-containing anti-smoking aid composition

In the same manner as in Example 1, except that Damascone and propylene glycol-containing anti-smoking aid composition of Examples 2 to 11 were prepared under the same conditions as in Table 1 below.

<Example 12-20> Damascone, propylene glycol and additional additive-containing anti-smoking aid composition

In the same manner as in Example 1, but was prepared under the same conditions as in Table 1 Damascone, propylene glycol and additional additive-containing anti-smoking aid composition of Examples 12-20.

Example 21 Damascone, Propylene Glycol and Glycerin-Containing Smoking Aid Composition

0.01 g of beta-damascone, 82 g of propylene glycol, and 17.99 g of glycerin were mixed to prepare a damascon-containing anti-smoking adjuvant composition.

<Examples 22-32> Damascone, propylene glycol and glycerin-containing non-smoking adjuvant composition

In the same manner as in Example 1, except that Damascone, propylene glycol and glycerin-containing non-smoking adjuvant compositions of Examples 22 to 32 were prepared under the same conditions as in Table 1 below.

<Examples 33 to 41> Damascone, Propylene Clinone, Glycerin and additional additive-containing anti-smoking aid composition

<Comparative Examples 1-11> Smoking cessation aid composition

In the same manner as in Example 1, but was prepared under the conditions as shown in Table 1 Comparative Examples 1 to 11 of the non-smoking auxiliary composition, Comparative Examples 3 and 10 was prepared without the addition of damascone, Comparative Example 11 is propylene Prepared without adding glycol.

division
Damascon (g) Propylene glycol (g)
Glycerin (g)
Additional additives (g)
Alpha beta delta Example 1 - 0.001 - 99.999 - - Example 2 - 0.01 - 99.99 - - Example 3 - One - 99 - - Example 4 - 4 - 96 - - Example 5 - 8 - 92 - - Example 6 - 10 - 90 - - Example 7 One - - 99 - - Example 8 - - One 99 - - Example 9 0.5 0.5 - 99 - - Example 10 - 0.5 0.5 99 - - Example 11 0.3 0.4 0.3 99 - - Example 12 One - - 98 - Vitamin C 1 Example 13 - One - 98 - Isoleucine 1 Example 14 - - One 98 - Menthol 1 Example 15 One - - 98 - Vanillin 1 Example 16 - One - 98 - Choco 1 Example 17 - - One 98 - Coffee 1 Example 18 One - - 98 - Strawberry flavor 1 Example 19 - One - 98 - Melon flavor 1 Example 20 - - One 98 - Peach flavor 1 Example 21 - 0.01 - 82 17.99 - Example 22 - One - 76 23 - Example 23 - 3 - 67 30 - Example 24 - 5 - 58 37 - Example 25 - 8 - 47 45 - Example 26 - 10 - 35 55 - Example 27 - 10 - 30 60 - Example 28  One - - 59 40 - Example 29 - - One 59 40 - Example 30 0.5 0.5 - 59 40 - Example 31 - 0.5 0.5 59 40 - Example 32 0.3 0.4 0.3 59 40 - Example 33 One - - 65 33 Vitamin A 1 Example 34 - One - 65 33 Leucine 1 Example 35 - - One 65 33 Xylitol 1 Example 36 One - - 65 33 Phytoncide 1 Example 37 - One - 65 33 Peppermint 1 Example 38 - - One 65 33 Spearmint 1 Example 39 One - - 65 33 Blueberry flavor 1 Example 40 - One - 65 33 Banana flavor 1 Example 41 - - One 65 33 Lemon flavor 1 Comparative Example 1 - 0.0001 - 99.9999 - - Comparative Example 2 - 20 - 80 - - Comparative Example 3 - - - 100 - - Comparative Example 4 - 0.0001 - 90 9.9999 - Comparative Example 5 - 20 60 20 - Comparative Example 6 - 20 - 20 60 - Comparative Example 7 - 0.1 - 95 4.9 - Comparative Example 8 - 9.5 - 90 0.5 - Comparative Example 9 - 5 - 30 65 - Comparative Example 10 - - - 90 10 - Comparative Example 11 - One - - 99 -

<Test Example 1> Evaluation of palatability of the Damascon-containing anti-smoking aid composition

The preference of the smoking cessation aid composition prepared in Examples 1 to 41 and Comparative Examples 1 to 11 was evaluated. Twenty male smokers were randomly selected and allowed to smoke electronic cigarettes filled with the smoking cessation aid compositions prepared in Examples 1 to 41 and Comparative Examples 1 to 11, respectively, in a smoking cessation aid cartridge. The degree of preference was evaluated based on the degree of smoke generation and tobacco taste and aroma. The evaluation results are shown in Table 2 below.

<Evaluation Criteria>

-Degree of smoke

1: no smoke

3: Some smoke

5: Smoke occurs similarly to smoking

7: Smoke occurs very similarly to smoking

-Cigarette Flavor and Aroma

1: taste and aroma not similar to smoking

3: taste and aroma are similar to smoking

5: Similar taste and aroma to smoking

7: Very similar in taste and aroma to smoking

division Smoke generation Tobacco flavor and aroma Example 1 4.8 5.4 Example 2 5.0 5.8 Example 3 5.0 6.2 Example 4 4.9 6.0 Example 5 4.8 5.9 Example 6 4.7 5.8 Example 7 4.9 6.0 Example 8 4.9 6.0 Example 9 5.0 6.1 Example 10 5.0 6.1 Example 11 5.0 6.1 Example 12 5.0 6.1 Example 13 5.1 6.1 Example 14 5.1 6.2 Example 15 5.0 6.2 Example 16 5.0 6.2 Example 17 5.1 6.1 Example 18 5.0 6.1 Example 19 5.1 6.1 Example 20 5.1 6.2 Example 21 5.7 5.5 Example 22 6.1 6.2 Example 23 6.2 6.0 Example 24 5.8 5.9 Example 25 5.7 5.8 Example 26 5.7 5.7 Example 27 5.7 5.7 Example 28 5.7 6.0 Example 29 5.8 6.0 Example 30 5.8 6.1 Example 31 5.9 6.1 Example 32 5.8 6.1 Example 33 6.1 6.0 Example 34 6.1 6.2 Example 35 6.1 6.1 Example 36 6.0 6.1 Example 37 6.1 6.0 Example 38 6.0 6.1 Example 39 6.0 6.0 Example 40 6.1 6.1 Example 41 6.0 6.0 Comparative Example 1 4.7 2.2 Comparative Example 2 4.6 1.9 Comparative Example 3 4.7 0.9 Comparative Example 4 6.6 2.3 Comparative Example 5 6.5 2.1 Comparative Example 6 4.5 2.0 Comparative Example 7 4.7 5.6 Comparative Example 8 4.5 5.7 Comparative Example 9 4.4 5.8 Comparative Example 10 6.6 1.1 Comparative Example 11 4.2 6.2

As shown in Table 2, Examples 1 to 12 prepared by adding Damascon and propylene glycol and Examples 13 to 20 prepared by adding Damascon, propylene glycol and additional additives were prepared without adding Damascon. Cigarette taste and aroma were better than Example 3.

In addition, Examples 21 to 32 prepared by adding Damascon, propylene glycol and glycerin and Examples 33 to 41 prepared by adding Damascon, propylene glycol, glycerin and additional additives were prepared without adding Damascon. Cigarette taste and aroma were better than Example 10, and since smoke similar to that of smoking was produced than that of Comparative Example 11, which was prepared without the addition of propylene glycol, it was found to be similar to cigarette smoking.

Thus, Damascon prepared by adding 0.001-10% by weight of Damascon (alpha-damascone, beta-damascone and delta-damascone) and 90-99.999% by weight of propylene glycol in Examples 1-20 according to the present invention. The non-smoking adjuvant and the Damascon-containing non-smoking adjuvant composition prepared by adding 0.001-10% by weight of Damascon, 30-90% by weight of propylene glycol and 5-60% by weight of glycerin in Examples 21-41 were similar to smoking. It was found that the taste and aroma of tobacco were excellent, and the preference was high.

<Test Example 2> Evaluation of smoking cessation effect of Damascon-containing anti-smoking aid composition

To evaluate the anti-smoking effect according to the Examples 1 to 8 and 21 to 29 and the anti-smoking aid composition prepared in Comparative Examples 1 to 11. Examples 1 to 8 and 21 to 29 and Comparative Examples 1 to 11 prepared in the non-smoking adjuvant composition was compared, and 560 people smokers 20 to 50 years old.

Experimental examples (560 persons) in the electronic cigarette inner cartridge of the head office (Evaco Co., Ltd.) from October 1, 2010 to October 30, 2010 (30 days) to Examples 1 to 8 and 21 to 29 and Comparative Examples Provided by dividing the e-cigarette and the extra fillings (each composition prepared in Examples 1 to 8 and 21 to 29 and Comparative Examples 1 to 11) filled with the smoking cessation aid composition prepared in 1 to 11 in groups of 20 people each And whenever a smoking desire occurs. After the experiment, we evaluated the success of smoking cessation and the success of smoking cessation due to withdrawal phenomenon. The evaluation results are shown in Table 3 below.

division Successful smoking Unsuccessful person quitting smoking due to withdrawal Example 1 15 5 Example 2 16 4 Example 3 17 3 Example 4 18 2 Example 5 17 3 Example 6 16 4 Example 7 15 5 Example 8 16 4 Example 21 15 5 Example 22 16 4 Example 23 18 2 Example 24 17 3 Example 25 17 3 Example 26 16 4 Example 27 15 5 Example 28 16 4 Example 29 15 5 Comparative Example 1 3 17 Comparative Example 2 9 11 Comparative Example 3 0 20 Comparative Example 4 5 15 Comparative Example 5 5 15 Comparative Example 6 4 16 Comparative Example 7 10 10 Comparative Example 8 9 11 Comparative Example 9 8 12 Comparative Example 10 0 20 Comparative Example 11 6 14

As shown in Table 3, the anti-smoking adjuvant composition prepared by the addition of propylene glycol and damascon (beta-damascone, alpha-damascone and delta-damascone) prepared in Examples 1 to 8 according to the present invention has a smoking cessation effect. 30 days after the end of the experiment, 15 to 18 people were found to have successfully quit smoking, but the anti-smoking supplement composition of Comparative Example 3 prepared without adding damascone was found to have no smoking cessation 30 days after the end of the anti-smoking effect experiment.

In addition, the anti-smoking adjuvant composition containing damascone (beta-damascone, alpha-damascone and delta-damascone), propylene glycol and glycerin prepared in Examples 21 to 29 was 15 to 18 people after the end of the anti-smoking effect experiment. Although it was shown that the smoking cessation was successful, Comparative Example 10 prepared without the addition of damascone was found to have no smoking cessation success, and Comparative Example 11 prepared without the addition of propylene glycol showed six non-smoking successes.

Thus, Damascon prepared by adding 0.001-10% by weight of Damascon (alpha-damascone, beta-damascone and delta-damascone) and 90-99.999% by weight of propylene glycol in Examples 1 to 8 according to the present invention. The non-smoking adjuvant and the Damascon-containing non-smoking adjuvant composition prepared by adding 0.001-10% by weight of Damascon, 30-90% by weight of propylene glycol, and 5-60% by weight of glycerin in Examples 21 to 29 may contain no absorbent nicotine. In addition, it has been found that the smoking cessation effect is excellent because of the ability to suppress smoking desire.

Claims (9)

Damascon 0.001-10 wt%; And
Propylene glycol 90-99.999% by weight;
Damascon-containing non-smoking adjuvant composition comprising a. Damascon 0.001-10 wt%;
Propylene glycol 30-90 wt%; And
5 to 60% by weight glycerin;
Damascon-containing non-smoking adjuvant composition comprising a. The method according to claim 1 or 2,
The damascon is a damascon-containing anti-smoking supplement composition, characterized in that at least one selected from the group consisting of alpha-damascone, beta-damascone and delta-damascone. The method according to claim 1 or 2,
0.001 to 10 parts by weight based on 100 parts by weight of the anti-smoking supplement composition of claim 1 or 2, at least one selected from the group consisting of vitamins and amino acids as a general nutrient, aroma and fruit flavor as a flavoring agent in the anti-smoking supplement composition Damascon-containing anti-smoking aid composition, characterized in that it further comprises. The method of claim 4, wherein
The vitamin is one selected from the group consisting of vitamin A, retinol, beta carotene, thiamine, riboflavin, niacin, vitamin C, vitamin B6, pantothenic acid, vitamin B12, folic acid, vitamin D, vitamin E, vitamin K, vitamins and thiamine Damascon-containing anti-smoking aid composition, characterized in that above. The method of claim 4, wherein
The amino acid is at least one member selected from the group consisting of isoleucine, leucine, lysine, methionine, cysteine, phenylalanine, tyrosine, threonine, tryptophan, valine, histidine, arginine, aspartic acid, glutamic acid, glycine, proline and serine Damascon-containing anti-smoking aid composition. The method of claim 4, wherein
The aroma is menthol, vanillin, chocolate, coffee, xylitol, phytoncide, peppermint, spearmint, chamomile, eucalyptus, thyme, geranium, jasmine, rosemary, lavender, lemongrass, pine needles, clobo, sage, bergamot, basil, bal Dalian's, Hishop, tea tree, mir and juniper Damascone-containing anti-smoking aid composition, characterized in that at least one member selected from the group consisting of. The method of claim 4, wherein
The fruit flavor is a group consisting of strawberry flavor, melon flavor, peach flavor, blueberry flavor, banana flavor, lemon flavor, mango flavor, apple flavor, orange flavor, grapefruit flavor, plum flavor, kiwi flavor, flavor, pineapple flavor and grape flavor Damascon-containing anti-smoking aid composition, characterized in that at least one selected from. A smoking cessation aid comprising the damascon-containing cessation aid composition according to any one of claims 1 and 2.